Y. Ravindranath

发表

Levels of p53 protein increase with maturation in human hematopoietic cells.

C. Wolkow, M. Kastan, O. Onyekwere, 1991, Cancer research.

Levels of p 53 Protein Increase with Maturation in Human Hematopoietic Cells 1

C. Wolkow, M. Kastan, O. Onyekwere, 2006 .

Relationship of p15 and p16 gene alterations to elevated dihydrofolate reductase in childhood acute lymphoblastic leukaemia

T. L. Witt, M. Amylon, B. Pollock, 2001, British journal of haematology.

Blood 94/4 (Aug 15)

Y. Ravindranath, J. Taub, L. Matherly, 1999 .

Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes.

Y. Ravindranath, Y. Ho, Robert M. Johnson, 2005, Free radical biology & medicine.

Periodic transfusions for sickle cell anemia and CNS infarction.

Y. Ravindranath, J. Lusher, S. Sarnaik, 1979, American journal of diseases of children.

Clinical Diagnosis of Red Cell Membrane Disorders: Comparison of Osmotic Gradient Ektacytometry and Eosin Maleimide (EMA) Fluorescence Test for Red Cell Band 3 (AE1, SLC4A1) Content for Clinical Diagnosis

Y. Ravindranath, Robert M. Johnson, S. Bagla, 2020, Frontiers in Physiology.

Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.

S. Raimondi, Y. Ravindranath, J. Taub, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes.

Robert Tibshirani, Yan Wang, Soheil Meshinchi, 2004, Blood.

Down syndrome preleukemia and leukemia.

P. Vyas, Y. Ravindranath, J. Taub, 2015, Pediatric clinics of North America.

Approach to severe anemia in children in the emergency room

Y. Ravindranath, A. Nahar, 2008 .

Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers.

J. Whetstine, Y. Ravindranath, J. Taub, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Distinctive phenotypes in two children with novel germline RUNX1 mutations - one with myeloid malignancy and increased fetal hemoglobin

Y. Ravindranath, C. Schiffer, L. A. Flore, 2020, Pediatric hematology and oncology.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.

R. Arceci, Y. Ravindranath, P. McCarthy, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia

Y. Ravindranath, S. Savaşan, S. Buck, 2005, Leukemia & lymphoma.

Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children.

Y. Ravindranath, S. Buck, S. Savaşan, 2000, Cytometry.

The Paradox of Myeloid Leukemia Associated with Down Syndrome.

Y. Ravindranath, J. Taub, H. Edwards, 2022, Biochemical pharmacology.

Melatonin cytotoxicity in human leukemia cells: relation with its pro‐oxidant effect

Y. Ravindranath, S. Savaşan, S. Buck, 2006, Fundamental & clinical pharmacology.

Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: A prospective multi‐institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA)

R. Arceci, Y. Ravindranath, A. Kulozik, 2014, Pediatric blood & cancer.

Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.

Y. Ravindranath, J. Pullen, J. Taub, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

The Role of Cytidine Deaminase and GATA1 Mutations in the Increased Cytosine Arabinoside Sensitivity of Down Syndrome Myeloblasts and Leukemia Cell Lines

Y. Ravindranath, J. Taub, L. Matherly, 2004, Cancer Research.

Treatment of Nonmetastatic Unilateral Retinoblastoma in Children

Y. Ravindranath, G. Reaman, M. D. de Dávila, 2018, JAMA ophthalmology.

Increased Erythrocyte Deformability in Fetal Erythropoiesis and in Erythrocytes Deficient in Glucose-6-Phosphate Dehydrogenase and Other Glycolytic Enzymes

Y. Ravindranath, Robert M. Johnson, G. Goyette, 1999, Pediatric Research.

Osmotic Scan Ektacytometry in Clinical Diagnosis

Y. Ravindranath, R. Johnson, Robert M. Johnson, 1996, Journal of pediatric hematology/oncology.

A large erythroid spectrin β‐chain variant

Y. Ravindranath, Robert M. Johnson, F. Brohn, 1992 .

Myelodysplastic syndrome in children: Changing definitions from FAB 1976 to WHO 2008 classification systems

Y. Ravindranath, 2011, Pediatric blood & cancer.

Drug Resistance in Acute Leukemia

R. Arceci, Y. Ravindranath, 2003 .

Therapy for childhood acute myeloid leukemia: Role of allogeneic bone marrow transplantation

Y. Ravindranath, E. Abella, 2000, Current oncology reports.

children with AML in remission : Pediatric Oncology Group Study 9421 Randomized use of cyclosporin A ( CsA ) to modulate P-glycoprotein in

F. Behm, S. Raimondi, M. Qumsiyeh, 2005 .

How Many Sources Should Be Cultured for the Diagnosis of a Blood Stream Infection in Children with Cancer?

Y. Ravindranath, Ronald L Thomas, D. Doganis, 2013, Pediatric hematology and oncology.

RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study

B. Vogelstein, J. Krischer, A. Preisinger, 1990, Genes, chromosomes & cancer.

A novel finding in pediatric leiomyosarcoma: Expanding spectrum of FGFR rearrangements in childhood cancers

Y. Ravindranath, B. Shehata, C. Shanti, 2020, Pediatric blood & cancer.

Single Nucleotide Polymorphisms in the Human Reduced Folate Carrier: Characterization of a High-Frequency G/A Variant at Position 80 and Transport Properties of the His 27 and Arg 27 Carriers 1

J. Whetstine, Y. Ravindranath, J. Taub, 2001 .

Early deaths in childhood cancer.

R. Severson, Y. Ravindranath, P. Chuba, 2000, Medical and pediatric oncology.

Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children.

M. Amylon, Y. Ravindranath, J. Pullen, 1997, Blood.

High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia.

Y. Ravindranath, J. Taub, L. Matherly, 2002, Blood.

Evolution of modern treatment of childhood acute leukemia and cancer: adventures and battles in the 1970s and 1980s.

Y. Ravindranath, 2015, Pediatric clinics of North America.

Treatment of familial erythrophagocytic lymphohistiocytosis with cyclosporine A.

Y. Ravindranath, E. Abella, K. Schultz, 1997, The Journal of pediatrics.

Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.

G. Lyman, T. Alonzo, R. Gerbing, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood

J. Krischer, J. Graham-Pole, A. Carroll, 1996 .

Changes in Bi-ventricular Function After Hematopoietic Stem Cell Transplant as Assessed by Speckle Tracking Echocardiography

Y. Ravindranath, S. Aggarwal, S. Savaşan, 2018, Pediatric Cardiology.

Recombinant interferon alfa given before and in combination with standard chemotherapy in children with acute lymphoblastic leukemia in first marrow relapse: a Pediatric Oncology Group pilot study.

B. Pollock, Y. Ravindranath, G. Buchanan, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-performance liquid chromatographic assay for methotrexate utilizing a cold acetonitrile purification and separation of plasma or cerebrospinal fluid.

R. Kauffman, Y. Ravindranath, M. Stout, 1985, Journal of chromatography.

Rapid Communication Comparison of DiOC 6 ( 3 ) Uptake and Annexin V Labeling for Quantification of Apoptosis in Leukemia Cells and NonMalignant T Lymphocytes From Children

Y. Ravindranath, S. Savaşan, S. Buck, 2000 .

Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia.

Y. Ravindranath, M. Aslan, S. Savaşan, 2003, Leukemia research.

Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans' syndrome.

Y. Ravindranath, I. Warrier, S. Savaşan, 2007, Clinical immunology.

The spectrum of Evans’ syndrome

Y. Ravindranath, I. Warrier, S. Savaşan, 1997, Archives of disease in childhood.

CD14/16 monocyte profiling in juvenile myelomonocytic leukemia

Y. Ravindranath, S. Bagla, S. Buck, 2020, Pediatric blood & cancer.

What's up with down syndrome and leukemia‐A lot!

Y. Ravindranath, J. Taub, 2011, Pediatric blood & cancer.

Down Syndrome and Acute Myeloid Leukemia: An Unique Genetic Sensitivity to Chemotherapy

Y. Ravindranath, J. Taub, Y. Ge, 2010 .

he Role of Cytotoxic Therapy with Hematopoietic tem Cell Transplantation in the Therapy of Acute yeloid Leukemia in Children : An Evidence-Based eview

R. Arceci, Y. Ravindranath, P. McCarthy, 2007 .

GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.

Y. Ravindranath, J. Taub, L. Matherly, 2005, Journal of the National Cancer Institute.

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000

S. Raimondi, C. Civin, Y. Ravindranath, 2005, Leukemia.

Down syndrome and acute myeloid leukemia: the paradox of increased risk for leukemia and heightened sensitivity to chemotherapy.

Y. Ravindranath, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821.

R. Gelber, Y. Ravindranath, S. Gelber, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.

Y. Ravindranath, J. Taub, L. Matherly, 1999, Blood.

Normal sister chromatid exchange frequency in long-term survivors with acute leukemia.

Y. Ravindranath, S. Inoue, L. Brown, 1982, Cancer research.

Mechanisms of Superior Anti-Tumor Cytotoxic Response of Interleukin 15-Induced Lymphokine-Activated Killer Cells

Y. Ravindranath, S. Savaşan, Ö. Özdemir, 2005, Journal of immunotherapy.

Mild erythrocytosis as a presenting manifestation of PIEZO1 associated erythrocyte volume disorders

Y. Ravindranath, Shengnan Wu, Tristan E. Knight, 2019, Pediatric hematology and oncology.

Congenital leukemia: two transient regressions without treatment in one patient.

Y. Ravindranath, A. Emami, R. Warrier, 1983, Pediatrics.

Clonal origin of erythroid cells in juvenile chronic myelogenous leukemia.

Y. Ravindranath, S. Inoue, N. Gohle, 1987, Blood.

Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study.

M. Relling, Y. Ravindranath, C. Pratt, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Glucose phosphate isomerase deficiency as a cause of hydrops fetalis.

Y. Ravindranath, I. Warrier, W. Valentine, 1987, The New England journal of medicine.

Infections in leukemic children: a prospective analysis.

Y. Ravindranath, J. Lusher, T. Shope, 1980, The Journal of pediatrics.

Cord blood lead level in an urban inner-city hospital.

S. Chawla, G. Natarajan, M. Dwaihy, 2016, Journal of neonatal-perinatal medicine.

T and B lymphocyte antigen-positive null cell leukemias.

Y. Ravindranath, W. D. Peterson, J. Kaplan, 1977, Blood.

Identification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the Children's Oncology Group

J. Fontana, Y. Ravindranath, J. Taub, 2008, Oncogene.

Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children.

M. Amylon, Y. Ravindranath, J. Pullen, 1997, Blood.

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

Y. Ravindranath, J. Taub, S. Savaşan, 2021, Annals of Hematology.

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies

C. Bloomfield, H. Gundacker, S. Raimondi, 2006, Leukemia.

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.

J. Krischer, J. Graham-Pole, Y. Ravindranath, 1996, The New England journal of medicine.

Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin.

Y. Ravindranath, J. Taub, M. Stout, 1997, Leukemia.

Down syndrome and the transient myeloproliferative disorder: why is it transient?

Y. Ravindranath, J. Taub, 2002, Journal of pediatric hematology/oncology.

WT1 expression at diagnosis does not predict survival in pediatric aml: A report from the Children's Oncology Group

R. Arceci, T. Alonzo, R. Gerbing, 2009, Pediatric blood & cancer.

Cystic fibrosis and anaemia in infancy

Y. Ravindranath, S. Savaşan, K. Bhambhani, 1997, The Lancet.

Erythrocyte Age-Dependent Changes of Membrane Protein 4.1: Studies in Transient Erythroblastopenia

Y. Ravindranath, Robert M. Johnson, F. Brohn, 1987, Pediatric Research.

Altered spectrin association and membrane fragility without abnormal spectrin heat sensitivity in a case of congenital hemolytic anemia

Y. Ravindranath, Robert M. Johnson, 1985, American journal of hematology.

Biochemical interactions between methotrexate and 1-β-d-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study

R. Krance, Y. Ravindranath, A. Testi, 2004, Cancer Chemotherapy and Pharmacology.

Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia

Y. Ravindranath, G. Kaspers, M. Rots, 2002, Leukemia.

Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.

R. Mohammad, Y. Ravindranath, J. Taub, 2000, Cancer research.

Leukemia in Down Syndrome : A Model of in Vivo and in Vitro in CCRF-CEM Leukemia Cells-d-Arabinofuranosylcytosine β Sensitivity and Metabolism of 1-- Synthase cDNA Transfection Alters the β Cystathionine-Updated

R. Mohammad, Y. Ravindranath, J. Taub, 2000 .

Significance of mediastinal mass in acute lymphoblastic leukemia.

Y. Ravindranath, W. Zuelzer, J. Kaplan, 1975, Pediatrics.

Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children

Y. Ravindranath, S. Savaşan, Jessica L. Spruit, 2019, Journal of pediatric hematology/oncology.

Congenital microangiopathic hemolytic anemia and thrombocytopenia with unusually large von Willebrand factor multimers and von Willebrand factor-cleaving protease.

Y. Ravindranath, J. Taub, M. Botterill, 2001, Journal of pediatric hematology/oncology.

High level of mitogen‐activated protein kinase phosphatase‐1 expression is associated with cisplatin resistance in osteosarcoma

Gen Sheng Wu, Y. Ravindranath, Junhao Zhou, 2008, Pediatric blood & cancer.

Patterns and correlates of preserved humoral immunity to vaccines in children following allogeneic hematopoietic stem cell transplantation

Y. Ravindranath, S. Savaşan, Jessica L. Spruit, 2020, Pediatric transplantation.

Down syndrome and leukemia: New insights into the epidemiology, pathogenesis, and treatment

Y. Ravindranath, 2005, Pediatric blood & cancer.

COMMENTARY Down Syndrome and Leukemia: New Insights Into the Epidemiology, Pathogenesis, and Treatment

Y. Ravindranath, 2005 .

Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells.

Y. Ravindranath, S. Savaşan, S. Buck, 2011, In vivo.

Generalized infantile myofibromatosis in a patient with Turner's syndrome: a trial of interferon-alpha.

Y. Ravindranath, R. Rabah, S. Savaşan, 1998, The Journal of pediatrics.

KLF1 E325K-associated Congenital Dyserythropoietic Anemia Type IV: Insights Into the Variable Clinical Severity

Y. Ravindranath, Robert M. Johnson, P. Gallagher, 2017, Journal of pediatric hematology/oncology.

Red cells from glutathione peroxidase-1-deficient mice have nearly normal defenses against exogenous peroxides.

Y. Ravindranath, R. Johnson, Y. Ho, 2000, Blood.

Acute lymphoid leukemia.

Y. Ravindranath, J. Lusher, 1978, Pediatric annals.

Predictive Factors for Blood Stream Infections in Children with Cancer

Y. Ravindranath, Ronald L Thomas, D. Doganis, 2013, Pediatric hematology and oncology.

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced‐dose chemotherapy on Children's Oncology Group trial A2971

R. Arceci, T. Alonzo, R. Gerbing, 2012, Cancer.

Improved Remission Induction Rate of Childhood AML: Preliminary Results of the AML02 Trial.

D. Campana, C. Pui, S. Meshinchi, 2005 .

Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood.

F. Behm, S. Raimondi, D. Head, 1994, Cancer genetics and cytogenetics.

7 Treatment of childhood acute myeloid leukaemia

Y. Ravindranath, J. Taub, 1996 .

t(5;9)(q11;q34): a novel familial translocation involving Abelson oncogene and association with hypereosinophilia.

Y. Ravindranath, G. Feldman, S. Bakhshi, 2003, Journal of pediatric hematology/oncology.

A Randomized Comparative Study of Purged Autologous Bone Marrow Transplantation Versus Intensive Multiagent Consolidation Chemotherapy in First Remission of Acute Myeloid Leukemia in Children (Pediatric Oncology Group Study—POG 8821)

S. Raimondi, J. Graham-Pole, A. Carroll, 1997 .

Children with hyperdiploid but not triple trisomy (+4,+10,+17) acute lymphoblastic leukemia have an increased incidence of extramedullary relapse on current therapies: A single institution experience

Y. Ravindranath, J. Taub, A. Sharathkumar, 2008, American journal of hematology.

A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study.

S. Grupp, D. Billheimer, Y. Ravindranath, 2007, Blood.

PROGNOSTIC FACTORS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: CORRELATION WITH TREATMENT RESPONSE

Y. Ravindranath, 1985 .

Open heart surgery in a hemophiliac patient. Hematologic management.

Y. Ravindranath, J. Lusher, E. Green, 1974, American journal of diseases of children.

Disseminated intravascular coagulation with trauma: treatment with exchange transfusion.

Y. Ravindranath, S. Sarnaik, A. Sarnaik, 1979, Pediatrics.

New leukemia in the course of therapy of acute lymphoblastic leukemia

Y. Ravindranath, J. Lusher, W. Zuelzer, 1978, American journal of hematology.

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.

R. Arceci, T. Alonzo, R. Gerbing, 2011, Blood.

Bilateral interstitial pneumonia in acute lymphoblastic leukemia

Y. Ravindranath, W. Zuelzer, A. J. Brough, 1976, American journal of hematology.

Therapy of childhood acute nonlymphocytic leukemia: the Pediatric Oncology Group experience (1977-1988).

J. Krischer, C. Civin, Y. Ravindranath, 1990, Haematology and blood transfusion.

Sirolimus rescue for tacrolimus‐associated post‐transplant autoimmune hemolytic anemia

Y. Ravindranath, I. Warrier, R. Shapiro, 2006, Pediatric transplantation.

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.

M. Relling, W. Evans, M. Holdsworth, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oxidant Damage to Erythrocyte Membrane in Glucose-6-Phosphate Dehydrogenase Deficiency: Correlation With In Vivo Reduced Glutathione Concentration and Membrane Protein Oxidation

Y. Ravindranath, Robert M. Johnson, G. Goyette, 1994 .

Interferon‐γ sensitizes osteosarcoma cells to fas‐induced apoptosis by up‐regulating fas receptors and caspase‐8

Y. Ravindranath, M. Glibetić, S. Buck, 2004, Pediatric blood & cancer.

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study

M. Amylon, J. Kurtzberg, M. Link, 1999, Leukemia.

Chromosomal analysis of metastatic retinoblastoma cells

Y. Ravindranath, W. Zuelzer, S. Inoue, 2004, Humangenetik.

The structural organization of skeletal proteins influences lipid translocation across erythrocyte membrane.

Y. Ravindranath, N. Mohandas, S. Ballas, 1985, The Journal of biological chemistry.

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

I. Bernstein, S. Raimondi, J. Radich, 2010, Blood.

Sequential Oral Hydroxyurea and Intravenous Cytosine Arabinoside in Refractory Childhood Acute Leukemia: A Pediatric Oncology Group Phase 1 Study

Y. Ravindranath, B. Camitta, D. Mahoney, 2008, Journal of pediatric hematology/oncology.

Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study.

A. Look, J. Krischer, Y. Ravindranath, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alkylsulphonic acid ion pairing with radial compression columns for determining plasma or cerebrospinal fluid 1-beta-D-arabinofuranosylcytosine in pediatric pharmacokinetic analysis.

Y. Ravindranath, M. Stout, 1995, Journal of chromatography. A.

Congenital transcobalamin II deficiency presenting atypically with a low serum cobalamin level: studies demonstrating the coexistence of a circulating transcobalamin I (R binder) complex

Y. Ravindranath, R. Carmel, 1984 .

Congenital transcobalamin II deficiency presenting atypically with a low serum cobalamin level: studies demonstrating the coexistence of a circulating transcobalamin I (R binder) complex.

Y. Ravindranath, R. Carmel, 1984, Blood.

Cytogenetics of juvenile type chronic granulocytic leukemia

Y. Ravindranath, W. Zuelzer, S. Inoue, 1977, Cancer.

Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.

D. Morton, C. Kung, S. Sheth, 2019, The New England journal of medicine.

A New Case of KLF1 G973A Mutation and Congenital Dyserythropoeitic Anemia (CDA)- Further Definition of Emerging New Syndrome and Possible Association with Gonadal Dysgenesis

A. Dombkowski, Y. Ravindranath, Robert M. Johnson, 2011 .

Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3‐ITD status: a report from the Children's Oncology Group

S. Raimondi, S. Meshinchi, T. Alonzo, 2014, British journal of haematology.

Development and validation of a single‐cell network profiling assay‐based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group

S. Meshinchi, T. Alonzo, R. Gerbing, 2013, British journal of haematology.

Recent advances in pediatric acute lymphoblastic and myeloid leukemia

Y. Ravindranath, 2003, Current opinion in oncology.

A pilot study of intermediate‐dose methotrexate and cytosine arabinoside, “Spread‐out” or “Up‐front,” in continuation therapy for childhood non‐T, non‐B acute lymphoblastic leukemia a pediatric oncology group study

J. Shuster, R. Krance, Y. Ravindranath, 1991 .

Antimetabolite‐based therapy in childhood T‐cell acute lymphoblastic leukemia: A report of POG study 9296

M. Holdsworth, M. Amylon, S. Winter, 2006, Pediatric blood & cancer.

Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.

S. Lipshultz, M. Borowitz, M. Devidas, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

J. Shuster, R. Krance, Y. Ravindranath, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Compound heterozygosity in PKLR gene for a previously unrecognized intronic polymorphism and a rare missense mutation as a novel cause of severe pyruvate kinase deficiency

Y. Ravindranath, S. Bagla, Jian-Ping Jin, 2019, Haematologica.

Identification of a novel variant in phosphoglycerate kinase-1 (PGK1) in an African-American child (PGK1 Detroit)

Y. Ravindranath, S. Bagla, A. Zaidi, 2019, Pediatric hematology and oncology.

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein

B. Sikic, Y. Ravindranath, M. Váradi, 2006, Leukemia.

A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.

John J Doyle, S. Nasim, A. Zipursky, 2006, Blood.

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.

S. Raimondi, N. Heerema, J. Harbott, 2007, Blood.

A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study.

J. Krischer, C. Civin, Y. Ravindranath, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survivors of acute lymphoblastic leukemia--risk of relapse after cessation of therapy.

Y. Ravindranath, J. Lusher, D. Soorya, 1981, Medical and pediatric oncology.

Exchange transfusion for hyperleukocytosis, anemia, and metabolic abnormalities in leukemia.

Y. Ravindranath, A. Emami, J. Lusher, 1981, The Journal of pediatrics.

Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report

M. Amylon, J. Kurtzberg, M. Link, 2000, Leukemia.

Primary Liposarcoma of Bone in an Adolescent

Y. Ravindranath, J. Ryan, D. Lucas, 1999 .

Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasms

Y. Ravindranath, S. Buck, S. Savaşan, 2004, Journal of Clinical Pathology.

Outcome of pediatric patients with acute myeloid leukemia (AML) and −5/5q− abnormalities from five pediatric AML treatment protocols: A report from the Children's Oncology Group

D. Johnston, S. Raimondi, N. Heerema, 2013, Pediatric blood & cancer.

Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.

J. Gurney, Y. Ravindranath, J. Taub, 1996, Blood.

Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498.

J. Krischer, Y. Ravindranath, E. Abella, 1992, Blood.

Outcome of Down Syndrome (DS) Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Treated with a Uniform Prospective Clinical Trial - Initial Report of the COG Trial A2971.

R. Arceci, T. Alonzo, R. Gerbing, 2006 .

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821

S. Raimondi, A. Carroll, Y. Ravindranath, 2000, Leukemia.

Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.

F. Behm, S. Raimondi, A. Carroll, 1999, Blood.

High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study.

J. Krischer, C. Civin, Y. Ravindranath, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biology of childhood acute lymphoblastic leukemia (ALL) in low/middle‐income countries—A case for using age at diagnosis for defining low‐risk ALL

Y. Ravindranath, 2015, Pediatric blood & cancer.

Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.

Yubin Ge, A. Dombkowski, Y. Ravindranath, 2006, Blood.

Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

J. Shuster, M. DeBaun, B. Pollock, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Further elucidation of mechanism of resistance to vincristine in myeloid cells: role of hypochlorous acid in degradation of vincristine by myeloperoxidase

Y. Ravindranath, S. Buck, S. Savaşan, 2000, Leukemia.

Forty-five-year follow-up of a childhood leukemia survivor: serendipity or karma?

Y. Ravindranath, 1999, Medical and pediatric oncology.

Down syndrome and acute myeloid leukemia. Lessons learned from experience with high-dose Ara-C containing regimens.

Y. Ravindranath, J. Taub, 1999, Advances in experimental medicine and biology.

Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

A. Look, J. Shuster, Y. Ravindranath, 1998, Leukemia & lymphoma.

Myeloblasts from Doen syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicine

Y. Ravindranath, M. Stout, S. Buck, 1997, Leukemia.

Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study.

J. Krischer, N. Winick, C. Civin, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary malignant lymphoma cutis in an infant: case report and review of literature.

Y. Ravindranath, J. Lusher, P. Bhanot, 1979, Pediatrics.

Genotype‐phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency

P. Newburger, D. Morton, M. Wlodarski, 2020, American journal of hematology.

Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.

P. Newburger, D. Morton, E. Neufeld, 2018, Blood.

Inhibition of Bone Marrow Stem Cell Growth In Vitro by Methylmalonic Acid: a Mechanism for Pancytopenia in a Patient with Methylmalonic Acidemia

Y. Ravindranath, A. Sarnaik, S. Inoue, 1981, Pediatric Research.

Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.

Y. Ravindranath, E. Abella, L. Lum, 1994, Bone marrow transplantation.

Two new variants of glucose‐6‐phosphate dehydrogenase associated with hereditary non‐spherocytic hemolytic anemia: G6PD wayne and G6PD huron

Y. Ravindranath, E. Beutler, 1987, American journal of hematology.

The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency

D. Morton, C. Kung, Y. Ravindranath, 2020, British journal of haematology.

Pyruvate kinase deficiency in children

D. Morton, E. Neufeld, S. Sheth, 2021, Pediatric blood & cancer.

Characterization of the severe phenotype of pyruvate kinase deficiency

D. Morton, S. Sheth, M. Wlodarski, 2019, American journal of hematology.

Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study

P. Newburger, D. Morton, E. Neufeld, 2018, Haematologica.

Second malignancy in acute lymphocytic leukemia.

Y. Ravindranath, J. Lusher, S. Inoue, 1982, American journal of diseases of children.

Molecular Characterization of 140 Patients in the Pyruvate Kinase Deficiency (PKD) Natural History Study (NHS): Report of 20 New Variants

P. Newburger, D. Morton, M. Wlodarski, 2015 .

Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK Study

D. Morton, C. Kung, J. Hixon, 2016 .

Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics

Y. Ravindranath, S. Buck, Manisha Gadgeel, 2016, Indian Journal of Hematology and Blood Transfusion.

Absence of inhibitory cells from patients with aplastic anemia or transient erythroblastopenia of childhood on the in vitro growth of erythroid colonies.

Y. Ravindranath, J. Lusher, S. Inoue, 1980, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

A Prospective Study of G-CSF Primed Bone Marrow from Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study.

S. Grupp, D. Billheimer, Y. Ravindranath, 2005 .

Successful Treatment of an Adolescent Male With Severe Refractory Evans Syndrome Using Bortezomib-based Therapy.

Y. Ravindranath, M. Callaghan, Tristan E. Knight, 2020, Journal of pediatric hematology/oncology.

Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.

P. Gimotty, Y. Ravindranath, J. Taub, 1995, Blood.

Evaluation of the Association Between Congenital Cytomegalovirus Infection and Pediatric Acute Lymphoblastic Leukemia

Lindsay A. Williams, H. Nelson, Y. Ravindranath, 2023, JAMA network open.

Primary embryonal rhabdomyosarcoma of long bone. Case report and review of the literature.

Y. Ravindranath, M. Zalupski, J. Ryan, 1996, The American journal of surgical pathology.

Racial D ifferences i n t he S urvival o f C hildhood B - Precursor A cute L ymphoblastic L eukemia: A P ediatric Oncology G roup S tudy

J. Shuster, M. DeBaun, B. Pollock, 2000 .

6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.

M. Relling, W. Evans, J. Neglia, 2014, Blood.

MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia : a Children ’ s Oncology Group study

M. Relling, W. Evans, J. Neglia, 2014 .

Perinatal leukemia: the surface antigens, cytochemistry and cytogenetic features.

Y. Ravindranath, A. Emami, R. Warrier, 1983, Indian pediatrics.

Cell‐mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere‐adjusted counts on three‐color flow cytometry

Y. Ravindranath, S. Savaşan, Ö. Özdemir, 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Excessive Cardiotoxicity Despite Excellent Leukemia-Free Survival for Pediatric Patients with Down Syndrome (DS) and Acute Myeloid Leukemia (AML): Results from POG (Pediatric Oncology Group) Protocol 9421.

Y. Ravindranath, J. Taub, Myron N. Chang, 2006 .

CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: In vitro drug sensitivity and outcome

S. Raimondi, Y. Ravindranath, Myron N. Chang, 2006, Leukemia & lymphoma.

Down Syndrome and Acute Myeloid Leukemia

Y. Ravindranath, J. Taub, 1999 .

Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia.

G. Peters, R. Pieters, Y. Ravindranath, 2005, Blood.

Acute myeloid leukemia in children and adolescents

Y. Ravindranath, G. Kaspers, 2004 .

Role of USF1 in the differential expression of the human deoxycytidine kinase gene in acute myeloid leukemia

Y. Ravindranath, M. Stout, S. Buck, 2005, Leukemia.

Splenic infarction and total functional asplenia in disseminated varicella.

Y. Ravindranath, I. Warrier, 1986, The Journal of pediatrics.

Constitutional balanced translocations in alveolar rhabdomyosarcoma.

Y. Ravindranath, E. Abella, J. Williams, 1998, Cancer genetics and cytogenetics.

Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.

A. Pappo, Y. Ravindranath, T. Vietti, 1990, Journal of the National Cancer Institute.

Recurrent Breast Relapses in a Patient with Acute Lymphoblastic Leukaemia following Allogeneic Bone Marrow Transplantation

Y. Ravindranath, E. Abella, S. Savaşan, 1998, Acta Haematologica.

Southeast Asian ovalocytosis in an African-American family.

Y. Ravindranath, R. Johnson, G. Goyette, 1994, Blood.

Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children’s Oncology Group Study POG 9421

D. Campana, C. Pui, Y. Ravindranath, 2013, Leukemia.

Treatment of acute promyelocytic leukemia in children: arsenic or ATRA

Y. Ravindranath, J. Feusner, J. Gregory, 2004, Leukemia.

Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers.

T. L. Witt, J. Whetstine, Y. Ravindranath, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

5,10‐methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children

Y. Ravindranath, L. Darga, J. Taub, 2008, Pediatric blood & cancer.

Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia

Y. Ravindranath, D. Becton, M. Chang, 2002, Leukemia.

Glucose phosphate isomerase (GPI) Tadikonda: Characterization of a novel Pro340Ser mutation

Y. Ravindranath, D. Paglia, G. Goyette, 2017, Pediatric hematology and oncology.

Plasma Homocysteine Levels, Methylene Tetrahydrofolate Reductase Polymorphisms, and the Risk of Thromboembolism in Children

Y. Ravindranath, J. Lusher, M. Chitlur, 2011, Journal of pediatric hematology/oncology.

Spontaneous splenic rupture in acute lymphoblastic leukemia: successful nonoperative management.

Y. Ravindranath, D. Soorya, A. Philippart, 1980, American journal of diseases of children.

Idiopathic thrombocytopenic purpura in children. The case for management without corticosteroids.

Y. Ravindranath, A. Emami, J. Lusher, 1984, The American journal of pediatric hematology/oncology.

The American Society of Pediatric Hematology/Oncology Distinguished Career Award goes to Jeanne Lusher, M.D.

Y. Ravindranath, 2002, Journal of pediatric hematology/oncology.

The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism.

Y. Ravindranath, Dae-Yeul Yu, Y. Ho, 2010, Free radical biology & medicine.

Acquired Pure Red Cell Aplasia and Acquired Amegakaryocytic Thrombocytopenia Associated With Clonal Expansion of T-Cell Large Granular Lymphocytes in a Patient With Lipopolysaccharide-responsive Beige-like Anchor (LRBA) Protein Deficiency.

Y. Ravindranath, S. Savaşan, S. Buck, 2019, Journal of pediatric hematology/oncology.

Acute megakaryoblastic leukemia with t(17;22)(q21;q13) and liver dysfunction.

Y. Ravindranath, S. Savaşan, A. Mohamed, 2004, Cancer genetics and cytogenetics.

Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report

J. Neglia, A. Angiolillo, Y. Ravindranath, 2022, Cancer.

IMFRA (Intermittent Intrathecal Methotrexate and Fractional Radiation) plus chemotherapy in childhood leukemia

Y. Ravindranath, J. Lusher, S. Sarnaik, 1976, American journal of hematology.

Oxidant damage to erythrocyte membrane in glucose-6-phosphate dehydrogenase deficiency: correlation with in vivo reduced glutathione concentration and membrane protein oxidation.

Y. Ravindranath, R. Johnson, Mohsen Saleh Elalfy, 2012, Blood.

Cytogenetic analysis of erythroleukaemia in two children - evidence of nonmalignant nature of erythron.

Y. Ravindranath, W. Zuelzer, S. Inoue, 2009, Scandinavian journal of haematology.

Second malignant neoplasms (SMNs) in retinoblastoma (RB)

Y. Ravindranath, J. Taub, P. Chuba, 1999 .

Prognostic Factors and Patterns of Failure in Childhood Acute Myeloid Leukemia: Experience on Pediatric Oncology Group Study # 8821

S. Raimondi, A. Carroll, Y. Ravindranath, 2001 .

Oxidation of glutathione peroxidase-deficient red cells by organic peroxides.

Y. Ravindranath, Y. Ho, Robert M. Johnson, 2002, Blood.

Endothelial Cell Injury of Carmustine (BCNU) in Hepatic Sinusoids: Contribution of Oxidation and Immune Reaction.

Y. Ravindranath, S. Savaşan, Ö. Özdemir, 2004 .

Phase I study of valspodar (PSC‐833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: A report from the Children's Oncology Group

R. Arceci, B. Sikic, Y. Ravindranath, 2010, Pediatric blood & cancer.

Targeted Therapies in Pediatric Acute Myeloid Leukemia - Evolving Therapeutic Landscape.

Y. Ravindranath, Avanti Gupte, Eman T Al-Antary, 2023, Indian journal of pediatrics.

T‐cell acute lymphoblastic leukemia with natural killer cell phenotype

Y. Ravindranath, S. Inoue, J. Kaplan, 1986, American journal of hematology.

A large erythroid spectrin beta-chain variant.

Y. Ravindranath, R. Johnson, F. Brohn, 1992, British journal of haematology.

High frequency of the 844ins68 cystathionine-β-synthase gene variant in Down syndrome children with acute myeloid leukemia

Y. Ravindranath, J. Taub, L. Matherly, 2002, Leukemia.

Treatment of refractory immune cytopenias in the 21st century‐how safe is rituximab?

Y. Ravindranath, 2005, American journal of hematology.

Acute lymphoblastic leukemia in a 46,XY/47,XYY mosaic male: clonal origin of leukemia in the XY-bearing stem-cell line.

Y. Ravindranath, J. Taub, S. Wolman, 1993, A M A Journal of Diseases of Children.

A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children’s Oncology Group (COG) study POG-9481

S. Nasim, A. Zipursky, Y. Ravindranath, 2006 .

J. Shuster, R. Krance, Y. Ravindranath, 1991, Cancer.

A variant translocation between chromosomes 4 and 11, t(4q;11p) in a child with acute leukemia.

Y. Ravindranath, S. Inoue, M. Tyrkus, 1985, The American journal of pediatric hematology/oncology.

An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India

J. Neglia, Y. Ravindranath, K. Schultz, 1993, Cancer.

Improved Outcome for Children with Acute Leukemia: How to Address Global Disparities

A. Veerman, R. Ribeiro, Y. Ravindranath, 2011 .

Central Nervous System Prophylaxis with Intermittent Intrathecal Methotrexate and Fractional Radiation in Childhood Acute Lymphoblastic Leukemia

Y. Ravindranath, I. Warrier, J. Lusher, 1983 .

Repetitive low-dose radiation therapy for acute stem-cell leukemia.

Y. Ravindranath, J. Lusher, W. Zuelzer, 1977, International Journal of Radiation Oncology, Biology, Physics.

Testicular relapse (TR) in childhood acute lymphoblastic leukemia (ALL)

Y. Ravindranath, J. Lusher, 1979 .

Single Cell Network Profiling (SCNP) Signatures Predict Response to Induction Therapy and Relapse Risk In Pediatric Patients with Acute Myeloid Leukemia: Children's Oncology Group (COG) Study POG-9421

S. Raimondi, R. Arceci, S. Meshinchi, 2010 .

The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).

J. Krischer, C. Civin, Y. Ravindranath, 1992, Leukemia.

The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism.

Y. Ravindranath, Dae-Yeul Yu, Y. Ho, 2010, Free radical biology & medicine.

A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.

S. Nasim, A. Zipursky, Y. Ravindranath, 2006, Blood.

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.

R. Arceci, T. Alonzo, R. Gerbing, 2011, Blood.

What's up with down syndrome and leukemia‐A lot!

Y. Ravindranath, J. Taub, 2011, Pediatric blood & cancer.

Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.

A. Dombkowski, Y. Ravindranath, J. Taub, 2006, Blood.

Clonal trisomy 11 in a child with acute leukemia: G banding vs. FISH.

Y. Ravindranath, O. Ozdemir, S. Savaşan, 2001, Medical and pediatric oncology.

In Response to Back to HiDAC

Y. Ravindranath, K. O'Dwyer, 2022, The Hematologist.

Down syndrome and leukemia: New insights into the epidemiology, pathogenesis, and treatment

Y. Ravindranath, 2005, Pediatric blood & cancer.

Myelodysplastic syndrome in children: Changing definitions from FAB 1976 to WHO 2008 classification systems

Y. Ravindranath, 2011, Pediatric blood & cancer.